activation repression oncogenic myc shape tumour-specific gene expression profiles 
mammalian cells myc oncoprotein binds thousands promoters- mitogenic stimulation primary lymphocytes myc promotes increase expression virtually genes contrast myc-driven tumour cells differ normal cells expression specific sets up-and downregulated genes considerable prognostic value- understand discrepancy studied consequences inducible expression depletion myc human cells murine tumour models changes myc levels activate repress specific sets direct target genes characteristic myc-transformed tumour cells three factors account specificity first magnitude response parallels change occupancy myc promoter functionally distinct classes target genes differ e-box sequence bound myc suggesting different cellular responses physiological oncogenic myc levels controlled promoter affinity second myc positively negatively affects transcription initiation independent effect transcriptional elongation third complex formation miz1 also known zbtb17 mediates repression multiple target genes myc ratio myc miz1 bound promoter correlates direction response 
